This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Academic Highlights

New Developments in the Treatment of Alzheimer’s Disease

Peter V. Rabins, MD, MPH; Neill Graff- Radford, MB BCh, FRCP; Gary W. Small, MD; and Roy Yaari, MD, MAS

Published: February 16, 2009

Article Abstract

Click to enlarge page

First identified as a disease process in the early 1900s, today Alzheimer’s disease (AD) looms as a public health crisis. In 2000, an estimated 4.5 million persons in the United States had mild, moderate, or severe AD; this figure could grow to 13.2 million by 2050. Peter V. Rabins, MD, MPH, brought together a group of experts to discuss ways to better diagnose and more effectively treat this rapidly growing population.


As the population ages and survival rates increase for patients with AD, not only will the number of persons with the disease increase rapidly, said Neill Graff-Radford, MB BCh, FRCP, but also the age distribution of persons with AD will change.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 70

Quick Links: